ERBB2 and neoplasm: Bocangel et al. [33] evaluated the treatment of a panel of Her-2/neu over-expressing cell lines and nude mice tumours with a combination of Ad-MDA-7 gene transfer and Trastuzumab/Herceptin, the anti-human epidermal growth factor receptor-2 (Her-2) monoclonal antibody.